共 560 条
[91]
Gu M(1994)The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist Eur J Clin Pharmacol 46 203-1334
[92]
Cassel JA(2004)Peripheral kappa-opioid agonists for visceral pain Br J Pharmacol 141 1331-439
[93]
Belanger S(2008)Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation Pain 138 423-185
[94]
Graczyk TM(1999)Effects of kappa opioids in the inflamed rat colon Pain 79 175-941
[95]
DeHaven RN(2007)Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats Neuropharmacology 53 930-186
[96]
Conway-James N(1988)Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists Pain 35 179-731
[97]
Koblish M(1957)A method for evaluating both non-narcotic and narcotic analgesics Proc Soc Exp Biol Med 95 729-897
[98]
Little PJ(1998)Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attenuates morphine withdrawal EMBO J 17 886-1463
[99]
DeHaven-Hudkins DL(1936)The addition of organomagnesium halides to pseudocodeine types. II. Preparation of nuclear alkylated morphine derivatives J Am Chem Soc 58 1457-2050
[100]
Dolle RE(1992)Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway Proc Natl Acad Sci USA 89 2046-124